Macaluso et al respond to Condom effectiveness and prostate-specific antigen
Macaluso, M.; Lawson, M.L.; Duerr, A.; Hortin, G.
American Journal of Epidemiology 157(4): 301-302
2003
ISSN/ISBN: 0002-9262 DOI: 10.1093/aje/kwf214Document Number: 245933
Document emailed within 0-6 h
Related Documents
Zaviacic, M.; Ablin, R.J. 2005: The use of prostate-specific antigen as a criterion for condom effectiveness American Journal of Epidemiology 162(7): 704Zaviacic, M.; Ablin, R.J. 2005: The use of prostate-specific antigen as a criterion for condom effectiveness American Journal of Epidemiology 162(7): 704
Walsh, T.; Warner, L.; Macaluso, M.; Frezieres, R.; Snead, M.; Wraxall, B. 2012: Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance Contraception 86(1): 55-61
Walsh, T.; Warner, L.; Macaluso, M.; Frezieres, R.; Snead, M.; Wraxall, B. 2012: Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance Contraception 86(1): 55-61
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Bahamondes, L.; Diaz, J.; Marchi, N.M.; Castro, S.; Villarroel, M.; Macaluso, M. 2008: Prostate-specific antigen in vaginal fluid after exposure to known amounts of semen and after condom use: comparison of self-collected and nurse-collected samples Human Reproduction 23(11): 2444-2451
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Nixon, R.G.; Lilly, J.D.; Liedtke, R.J.; Batjer, J.D. 1997: Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen Archives of Pathology and Laboratory Medicine 121(4): 385-391
Purnell, D.M.; Heatfield, B.M.; Trump, B.F. 1984: Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen Cancer Research 44(1): 285-292
Fornara, P.; Sturm, W.; Fabricius, P.G.; Schmiedt, E. 1987: Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer Der Urologe. Ausg. a 26(3): 158-161
Wang, W.; Mo, Z.-N. 2010: Advances in prostate-specific membrane antigen targeted therapies for prostate cancer Zhonghua Nan Ke Xue 16(6): 547-551
Bostwick, D.G. 1994: Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer American Journal of Clinical Pathology 102(4 Suppl 1): S31-S37
Obralic, N.; Kulovac, B.; Aganovic, D.; Junuzovic, D. 2009: Values of prostate specific antigen in patients with operable prostate carcinoma Medicinski Arhiv 63(1): 34-37
Semjonow, A.; Hertle, L. 1995: Can the tumor stage of prostate carcinoma be determined with the aid of prostate-specific antigen? Der Urologe. Ausg. a 34(4): 290-296
Schäfer, U.; Micke, O.; Hampel, G.; Brandt, B.; Bovenschulte, A.; Semjonow, A.; Willich, N. 1997: The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer Anticancer Research 17(4b): 2983-2986
Kelly, W.K.; Slovin, S.; Scher, H.I. 1996: Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 8-14
Lieberman, S. 1999: Can percent free prostate-specific antigen reduce the need for prostate biopsy? Effective Clinical Practice: Ecp 2(6): 266-271
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Hardeman, S.W.; Wake, R.W.; Soloway, M.S. 1989: Two new techniques for evaluating prostate cancer. The role of prostate-specific antigen and transrectal ultrasound Postgraduate Medicine 86(2): 197-8 201 204 Passim
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26